If enacted, H7345 will amend various titles within the Rhode Island General Laws. It will require insurance plans to cover up to twenty sessions of neurofeedback therapy, ensuring that individuals in the target groups have financial assistance for this treatment modality. The legislation represents a progressive step towards recognizing alternative therapies in mental health treatment, potentially increasing the acceptance and integration of such methods into traditional healthcare frameworks.
Summary
House Bill 7345, introduced in 2022, aims to establish a pilot program that mandates insurance coverage for neurofeedback therapy in Rhode Island. Neurofeedback therapy is a non-invasive mental health treatment that utilizes technology to help individuals manage their mental states by measuring brain activity and other physiological processes. The bill specifically targets two groups: individuals under 21 years of age and military members or veterans diagnosed with post-traumatic stress disorder (PTSD). This initiative is designed to enhance access to mental health care for these vulnerable populations, especially given the increasing awareness of mental health issues among youth and veterans.
Contention
Notable points of contention surrounding H7345 may involve discussions about the efficacy and scientific backing of neurofeedback therapy compared to conventional treatments. Critics may argue that while the therapy shows promise, more rigorous studies are needed to substantiate its benefits for trauma and stress management. Additionally, there could be concerns about the fiscal implications of mandating coverage for this therapy on insurance providers and the overall healthcare system.
Provides for the licensing and regulation of the practice of neurofeedback therapy; defines practice of neurofeedback therapy; establishes state board of neurofeedback therapy and the requirements to qualify for a license as a neurofeedback therapist.
Provides for the licensing and regulation of the practice of neurofeedback therapy; defines practice of neurofeedback therapy; establishes state board of neurofeedback therapy and the requirements to qualify for a license as a neurofeedback therapist.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Adds a new section which sets forth conditions for pharmacists to prescribe tobacco cessation/drug therapies, programs approved by the state board of pharmacy. The cessation therapies would be covered by all health insurance carriers on or after 1/1/25.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Adds new sections that set forth conditions for pharmacists to prescribe tobacco cessation drug therapies, including education approved by state board of pharmacy. The cessation therapies to be covered by all health insurance carriers on or after 1/1/26.
Insurance: health insurers; coverage for medically necessary treatment related to or as a result of an acquired brain injury; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406cc.